Provide your email for confirmation

Tell us a bit about yourself

country *

Please provide your email address

welcome to Rappler

Login

To share your thoughts

Don't have an account?

Login with email

Check your inbox

We just sent a link to your inbox. Click the link to continue signing in. Can’t find it? Check your spam & junk mail.

Didn't get a link?

Use password?

Login with email

Reset password?

Please use the email you used to register and we will send you a link to reset your password

Check your inbox

We just sent a link to your inbox. Click the link to continue resetting your password. Can’t find it? Check your spam & junk mail.

Didn't get a link?

Sign up

Ready to get started

Already have an account?

Sign up with email

By signing up you agree to Rappler’s Terms and Conditions and Privacy

Check your inbox

We just sent a link to your inbox. Click the link to continue registering. Can’t find it? Check your spam & junk mail.

Didn't get a link?

Join Rappler+

Join Move

How often would you like to pay?

Annual Subscription

Monthly Subscription

Your payment was interrupted

Exiting the registration flow at this point will mean you will loose your progress

Your payment didn’t go through

Exiting the registration flow at this point will mean you will loose your progress

welcome to Rappler+

welcome to Move

welcome to Move & Rappler+

Drug against alcoholism works, researchers claim

PARIS, France – French researchers provided fresh evidence Friday, March 17, to support claims that a drug touted as a miracle cure for alcoholism, and prescribed for this purpose in France, actually works.

The drug, baclofen, had "a positive effect" at high doses in reducing alcohol consumption over a year of treatment, according to study results released at a conference in Paris.

Developers reported on a drug trial named Bacloville, conducted among 320 heavy drinkers aged 18 to 65 between May 2012 and June 2013.

The trial compared the safety and efficacy of the drug given to some participants at high doses, to a "dummy" placebo pill given to others.

Neither the trial participants nor their monitors knew who was getting which pill. The patients were not asked to refrain from alcohol.

About 57% of those who got the real drug stopped drinking or drank less, compared to 37% of those who got the dummy drug.

A second study, dubbed Alpadir, also reported Friday that people who received the medicine made bigger cuts in drinking compared to those given a placebo.

French health authorities gave provisional approval for use of baclofen, originally designed and widely used to treat muscle spasms, in 2014 for the treatment of alcoholism.

Many people in other countries are thought to use the drug without a prescription to fight alcoholism.

Interest was sparked in 2008 by a book, "Le Dernier Verre" (The Last Drink), by French-American cardiologist Olivier Ameisen, who claimed to have self-treated his alcoholism with high doses of baclofen.

A subsequent French trial found high doses of the drug caused a significant percentage of heavy drinkers to give up or moderate their intake.

Several trials since then have come up with contradictory findings.

Last year, Dutch researchers in a different study found the drug may work no better than counseling.

Without proof of its efficacy, prescribing high doses of the drug known as baclofen may be irresponsible, they warned at the time.

Ethypharm, the laboratory developing the drug, said Friday it would submit an application by month-end for the commercialization of baclofen for the treatment of alcoholism in France.

According to the UN's World Health Organization, 3.3 million deaths around the globe every year are the result of harmful alcohol use – almost 6% of all deaths. – Rappler.com